Sales Contact
T: +33 1 4770 3024
Email
Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview

 

> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe

Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [875 EMAT Reports], which includes:

 

Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.

 

The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.

 

The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.

 

Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
21/08/2018 Vivalto Sante Capio Gestion Rhône Clinics and hospitals *** 90851
29/06/2018 Private Group led by MBO Partneraires Laboratoires Embryolisse Hauts-De-Seine Personal Products * 90252
29/06/2018 Private Group led by CVC, PSP Investments and StepStone Recordati Italy Pharmaceuticals, Biomedical Research Laboratory *** 90264
20/04/2018 Private Group Led by Axcel Management Orion Diagnostica Finland Diagnostic Medical Equipment * 89193
03/04/2018 Fagron Humco Texas Pharmaceuticals, Biomedical Research Laboratory ** 90095
12/03/2018 Private Group led by Adolfsen Group Frösunda Omsorg Sweden Care Home, Specialist Care ** 88688
25/01/2018 Dechra Pharmaceuticals AST Farma & Le Vet Beheer Netherlands Veterinary Pharmaceuticals ** 88864
17/01/2018 Private Group led by Eurazeo Groupe C2S Loire Clinics and hospitals * 90832
02/01/2018 La Phocéenne de Cosmétique (Le Petit Olivier) Biocos Marketing Développement (Lovea) Isère Personal Products * 88075
08/12/2017 Medtronic Crospon Ireland Diagnostic Medical Equipment * 88215
08/11/2017 Private Group Led by Fremont Realty Capital Porthaven Group United Kingdom Care Home * 88720
24/10/2017 Private Group led by Antin Infrastructure Partners Almaviva Sante Bouches-Du-Rhône Clinics and hospitals * 90840
05/10/2017 Hut Group Illamasqua England Personal Products *** 91073
29/09/2017 Capital Care Group Anville Court United Kingdom Care Home * 88697
31/07/2017 Cantel Medical BHT Group Germany Medical Equipment ** 86166
24/07/2017 Private Group Led by KKR Nature's Bounty Co. (Formerly NBTY) United States Pharmaceuticals, Personal Products, Food Complements * 85250
10/07/2017 Eurofins Scientific Amatsigroup Hérault Laboratory Testing Services, Biomedical Research Laboratory ** 86072
05/07/2017 Vivalto Sante Clinique St Germain Yvelines Clinics and hospitals ** 90859
23/06/2017 Animalcare Group Ecuphar Belgium Veterinary Pharmaceuticals *** 87154
08/06/2017 Private Group Led by Intermediate Capital Group and Sagesse Retraite Sante DomusVi Group Hauts-De-Seine Care Home, Specialist Care *** 87458
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report